宋少莉副主任醫(yī)師
上海交通大學醫(yī)學院附屬仁濟醫(yī)院核醫(yī)學科
擅長領域:1. 難治性甲亢的碘-131治療:① 甲狀腺腫大明顯;② 抗甲狀腺藥物療效差、過敏或出現(xiàn)白細胞減少、肝功能損害等禁忌;③ 甲亢術后復發(fā);④ 甲亢合并心臟病、血細胞減少、糖尿病、肝功能損害、腎功能損害。?
執(zhí)業(yè)經(jīng)歷: 職 稱:副主任醫(yī)師 院 區(qū):東院,南院 科 室:核醫(yī)學科 醫(yī)療專長:1. 難治性甲亢的碘-131治療:① 甲狀腺腫大明顯;② 抗甲狀腺藥物療效差、過敏或出現(xiàn)白細胞減少、肝功能損害等禁忌;③ 甲亢術后復發(fā);④ 甲亢合并心臟病、血細胞減少、糖尿病、肝功能損害、腎功能損害。 門診時間:周五上午專家門診 教育經(jīng)歷1991.09 - 1996.06 蘭州大學醫(yī)學院臨床醫(yī)學系,獲醫(yī)學學士學位; 1996.07-2005.07 蘭州大學醫(yī)學院第一附屬醫(yī)院核醫(yī)學科工作,住院醫(yī)師、主治醫(yī)師; 其中2001.09-2003.07 蘭州大學醫(yī)學院人體解剖與組織胚胎專業(yè)碩士學位; 2005.08-2008.06 上海交通大學醫(yī)學院影像醫(yī)學與核醫(yī)學專業(yè),獲博士學位; 2008.07-2009.11 上海交通大學醫(yī)學院附屬仁濟醫(yī)院核醫(yī)學科工作,主治醫(yī)師; 2009.11-2010.12 美國MD安德森癌癥中心分子影像診斷系博士后; 2011.01-2011.11 上海交通大學醫(yī)學院附屬仁濟醫(yī)院核醫(yī)學科工作,主治醫(yī)師; 2011.12- 至今 上海交通大學醫(yī)學院附屬仁濟醫(yī)院核醫(yī)學科工作,副主任醫(yī)師。 學術職務 中華醫(yī)學會核醫(yī)學分會第九屆青年委員; 中國生物物理學會分子影像學專業(yè)委員會第一屆青年委員; 中華醫(yī)學會核醫(yī)學分會腫瘤學組委員; 上海醫(yī)學會核醫(yī)學分會青年學組副組長; 上海核醫(yī)學會科普與健康促進學組委員; 上海市影像醫(yī)學與核醫(yī)學重點學科骨干加學科秘書 論文著作 1. Song SL*, Xiong CY, Lu Wei, Ku Geng, Huang Gang, and Li Chun*. Novel apoptosis imaging probe predicts early chemotherapy response in preclinical models: a comparative study with 18F-FDG PET. Journal of Nuclear Medicine. J Nucl Med. 2013 ;54(1):104-10.(SCI IF = 6.381). 2. Zhu Y, Lu J, Wei X, Song S, Huang G*. The Predictive Value of Interim and Final [18F] Fluorodeoxyglucose Positron Emission Tomography after Rituximab-Chemotherapy in the Treatment of Non-Hodgkin's Lymphoma: A Meta-Analysis. Biomed Res Int. 2013; 2013:275805. doi: 10.1155/2013/275805. (SCI IF=2.8) 3. Yang DJ*, Tsai FY, Inoue T, Liao MH, Kong FL, Song S. Molecular imaging-guided theranostics and personalized medicine. Biomed Res Int. 2013; 859453. doi: 10.1155/2013/859453. (SCI IF=2.8) 4. Yu Z, Huang L, Zhang T, Yang F, Xie L, Liu J, Song S, Miao P, Zhao L, Zhao X, Huang G*. PIM2 phosphorylates PKM2 and promotes Glycolysis in Cancer Cells. J Biol Chem. 2013 Oct 18. (SCI IF=5.117) 5. Li J, Zhao S, Zhou X, Zhang T, Zhao L, Miao P, Song S, Sun X, Liu J, Zhao X, Huang G*. Inhibition of lipolysis by mercaptoacetate and etomoxir specifically sensitize drug-resistant lung adenocarcinoma cell to paclitaxel. PLoS One. 2013 ;8(9):e74623. (SCI IF=4.092) 6. Tang S, Huang G, Tong X, Xu L, Cai R, Li J, Zhou X, Song S, Huang G*, Cheng J. Role of SUMO-specific protease 2 in reprogramming cellular glucose metabolism. PLoS One. 2013 ;8(5):e63965. (SCI IF=4.092) 7. Wang Z, Lu J, Gong J, Zhang L, Xu Y, Song S, Chen K, Liu F, Huang G*. CT-Guided Radioactive (125)I Seed Implantation Therapy of Symptomatic Retroperitoneal Lymph Node Metastases. Cardiovasc Intervent Radiol. 2014;37(1):125-31 8. Zhang C, Liu J, Tong J, Sun X, Song S, Huang G*. 18F-FDG-PET evaluation of pathological tumour response to neoadjuvant therapy in patients with NSCLC. Nucl Med Commun. 2013; 34(1):71-77. 9. #Zhao J, #Song SL, Zhong M, Li C. Dual-Modal Tumor Imaging via Long-Circulating Biodegradable Core-Cross-Linked Polymeric Micelles. ACS Macro Letters.2012;1:150-153. (共同第一作者). 10. Song SL, Xiong CY, Zhou M, Li C*. Small Animal PET Imaging of Tumor Damage Induced by Photothermal Ablation Therapy with 64Cu-Bis-DOTA-Hypericin. J Nucl Med.2011;52(5)792-800. (SCI IF = 7.022). 11. Song SL, Deng C, Wen LF, Liu JJ, Huang G*. (18)F-FDG PET/CT-related metabolic parameters and their value in early prediction of chemotherapy response in a VX2 tumor model. Nucl Med Biol. 2010;37(3):327-333.(SCI IF = 2.620) 12. Song SL, Liu JJ, Huang G*, Wang ZH. Changes in 18F-FDG uptake within minutes after chemotherapy in a rabbit VX2 tumor model. J Nucl Med. 2008;49(2):303-309. (SCI IF = 6.662). 13. 宋少莉, 劉建軍, 王兆海, 萬良榮 , 孫曉光, 黃鋼*.18F-FDG PET/CT早期監(jiān)測小劑量順鉑在體化療敏感性的實驗研究[J].核技術, 2009,(8):614-619. EI收錄. 14. Song JG, Li HH, Cao YF, Lv X, Zhang P, Li YS, Zheng YJ, Li Q, Yin PH, Song SL, Wang HY, Wang XR. Electroacupuncture improves survival in rats with lethal endotoxemia via the autonomic nervous system. Anesthesiology. 2012;116(2):406-14.( IF=5.124 ) 15. Lv X, Song JG, Li HH, Ao JP, Zhang P, Li YS, Song SL, Wang XR. Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice.World J Gastroenterol. 2011 28;17(48):5267-73.(SCI IF = 2.5) 16. Ku G, Zhou M, Song S, Huang Q, Hazle J, Li C. Copper Sulfide Nanoparticles As a New Class of Photoacoustic Contrast Agent for Deep Tissue Imaging at 1064 nm. ACS Nano. 2012 28;6(8):7489-96. (SCI IF = 10.774) 17. Lu W, Xiong C, Zhang R, Shi L, Huang M, Zhang G, Song SL, Huang Q, Liu GY, Li C. Receptor-mediated transcytosis: A mechanism for active extravascular transport of nanoparticles in solid tumors. J Control Release. 2012;161(3):959-66. (SCI IF = 5.732) 18. Lu W, Melancon MP, Xiong C, Huang Q, Elliott A, Song SL, Zhang R, Flores LG 2nd, Gelovani JG, Wang LV, Ku G, Stafford RJ, Li C. Effects of photoacoustic imaging and photothermal ablation therapy mediated by targeted hollow gold nanospheres in an orthotopic mouse xenograft model of glioma. Cancer Res. 2011;71(19):6116-21.(SCI IF= 7.856) 19. Xiong CY, Brewer K, Song SL, Zhang R, Lu W, Wen XX, and Li C. Peptide-Based Imaging Agents Targeting Phosphatidylserine for the Detection of Apoptosis. Journal of Medicinal Chemistry.2011; 54(6):1825-1835. ( SCI IF = 4.898). 20. Zhou M, Zhang R, Huang M, Lu W, Song SL, Melancon MP, Tian M, Liang D, Li C. A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. J Am Chem Soc. 2010 3; 132(43):15351-15358. (SCI IF = 8.58) 21. Xiong CY, Huang M, Zhang R, Song SL, Lu W, Flores L, Gelovani J, and Li C. In vivo microPET/CT imaging of EphB4 receptors using 64Cu-labeled peptides. J Nucl Med. 2011; 52: 241-248. (SCI IF = 6.424) 22. Lu W, Melancon M, Xiong CY, Huang Q, Elliot A, Song SL, Zhang R, Flores II LG. Gelovani JG, Wang LV. Ku G, Stafford J, Li C. Cancer theranostics: photoacoustic imaging and photothermal ablation therapy mediated by targeted hollow gold nanospheres in an orthotopic glioma xenograft model. Cancer Res. 2011 71(19):6116-6121. (SCI IF = 7.543) 23. Li SJ, Guo W, Ren GX, Huang G, Chen T, Song SL. Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography. Br J Oral Maxillofac Surg. 2008;46(3):180-186.(SCI IF = 0.787) 24. Song JG, Cao YF, Sun YM, Ge YH, Xu XW, Yang LQ, Liu ZQ, Song SL, Yu WF. Baroreflex sensitivity is impaired in patients with obstructive jaundice. Anesthesiology. 2009;111(3):561-565.(SCI IF = 5.128) 25. Tang S, Huang G, Liu J, Liu T, Treven L, Song SL, Zhang C, Pan L, Zhang T. Usefulness of (18)F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: A meta-analysis. Eur J Radiol. 2009: DOI 19854016 (SCI IF = 2.339) 26. 宋少莉, 劉建軍, 王兆海, 萬良榮, 孫曉光, 黃鋼.18F-FDG PET/CT早期監(jiān)測小劑量順鉑在體化療敏感性的實驗研究[J].核技術, 2009, (8):614-619. 27. 宋少莉, 王兆海, 劉建軍, 萬良榮, 吳書其, 黃鋼. 兔接種VX2腫瘤的18F-FDGPET/CT觀察[J].腫瘤,2008,28(9):758-762. 28. 宋少莉, 黃鋼, 劉建軍, 孫曉光, 施一平, 陳虞梅, 萬良榮.PET/CT在肝癌肝移植術后患者中的臨床應用[J].上海交通大學學報:醫(yī)學版,2007,27(4):424-427. 29. 宋少莉, 劉亞濤, 劉純, 劉亞麗, 陳延世, 黃鋼.肌鈣蛋白Ⅰ評價心臟矯治術心肌損傷的作用[J].上海交通大學學報:醫(yī)學版,2006,26(5):516-518. 30. 宋少莉, 周斌, 王宏亮. Bax、Bcl-2在兔梗阻性黃疸腎損傷作用的實驗研究[J].西北國防醫(yī)學雜志,2004,25(5):339-341. 31. 宋少莉, 周斌, 程彥斌, 王宏亮, 湯曉琴.血塞通注射液對梗阻性黃疸腎損傷的保護機制[J].第四軍醫(yī)大學學報,2004,25(15):1368-1371. 32. 宋少莉, 程彥斌, 周斌, 湯曉琴.內皮素在實驗性兔梗阻性黃疸腎損傷作用的實驗研究[J].中華實用醫(yī)學,2003,5(21):7-9. 創(chuàng)新專利 2010年發(fā)明專利1項。 獲得榮譽 1. 2011年獲得“上海交通大學醫(yī)學院新百人計劃”; 2. 2011年獲得上海市浦江人才計劃; 3. 2011年中華醫(yī)學會第九屆全國核醫(yī)學年會優(yōu)秀壁報設計獎; 4. 2011年上海市科技進步獎2等獎 第8完成人 5. 2009年獲得上海市優(yōu)秀博士論文; 6. 2009年中華醫(yī)學科技進步獎三等獎 第7完成人。 7. 2009年中華醫(yī)學會第八屆全國核醫(yī)學年會優(yōu)秀現(xiàn)場交流獎。 詳細介紹
*以下號源由妙手醫(yī)生專業(yè)認證,僅展示近4周號源
馮雪鳳主任醫(yī)師
南京鼓樓醫(yī)院 · 核醫(yī)學科門診
擅長:1. 難治性甲亢的碘-131治療:① 甲狀腺腫大明顯;② 抗甲狀腺藥物療效差、過敏或出現(xiàn)白細胞減少、肝功能損害等禁忌;③ 甲亢術后復發(fā);④ 甲亢合并心臟病、血細胞減少、糖尿病、肝功能損害、腎功能損害。?
李文亮主任醫(yī)師
河南省腫瘤醫(yī)院 · 核醫(yī)學門診
擅長:1. 難治性甲亢的碘-131治療:① 甲狀腺腫大明顯;② 抗甲狀腺藥物療效差、過敏或出現(xiàn)白細胞減少、肝功能損害等禁忌;③ 甲亢術后復發(fā);④ 甲亢合并心臟病、血細胞減少、糖尿病、肝功能損害、腎功能損害。?
王峰主任醫(yī)師
南京市第一醫(yī)院 · 核醫(yī)學科
擅長:1. 難治性甲亢的碘-131治療:① 甲狀腺腫大明顯;② 抗甲狀腺藥物療效差、過敏或出現(xiàn)白細胞減少、肝功能損害等禁忌;③ 甲亢術后復發(fā);④ 甲亢合并心臟病、血細胞減少、糖尿病、肝功能損害、腎功能損害。?